Article
<i>Lodhrasavam</i> modulates liver–adipose–pancreas axis to ameliorate MASLD: Observations from <i>In vitro</i> and <i>in vivo</i> models of hepatic and metabolic dysfunction
2023-07-07
Abstract excerpt
<h4>Background</h4> Metabolic-dysfunction associated steatotic liver disease (MASLD) is a complex, multifactorial condition and a leading cause of liver-related morbidity worldwide. Due to its heterogeneous pathogenesis, conventional single-target therapies often show limited efficacy. Multicomponent ayurveda formulations offer a promising alternative through their multitargeted actions. This study explores the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3984837c-47a8-515a-8186-5310b08819f1
- DOI
- 10.1101/2023.07.05.547893
